| Shelby Heyn, CCC-SLP | |
|
804 Wright St, Brainerd, MN 56401-4441 | |
| (218) 829-1407 | |
| Not Available |
| Full Name | Shelby Heyn |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 804 Wright St, Brainerd, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669186706 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 518141 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shelby Heyn, CCC-SLP 7273 Clearwater Rd Apt 302, Baxter, MN 56425-5908 Ph: (218) 820-0189 | Shelby Heyn, CCC-SLP 804 Wright St, Brainerd, MN 56401-4441 Ph: (218) 829-1407 |
News Archive
Individuals born preterm are at increased risk for a range of psychiatric disorders in young adulthood, researchers report.
A group of Ohio public health officials and community workers on Wednesday met to discuss strategies to address racial health disparities in the state and also to develop a plan of action, the Akron Beacon Journal reports.
A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.
A new UCLA study shows that changes in certain brain receptors can affect seizures and anxiety during the menstrual cycle-findings that could lead to novel therapies for premenstrual dysphoric disorder (PMDD, formerly known as PMS) and other central nervous system symptoms associated with the menstrual cycle.
CMS officials on Friday announced that the agency this year will increase funding by $15 million to a total of $50 million to organizations that advise Medicare beneficiaries on prescription drug and health plan choices, CQ HealthBeat reports.
› Verified 9 days ago
Mrs. Renae Suzanne Stueber, MS, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Nw 6th St, Brainerd, MN 56401 Phone: 218-824-7030 Fax: 218-824-7030 | |
Alle C Bebeau, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2016 S 6th St, Brainerd, MN 56401 Phone: 218-828-7375 | |
Andrea Rhuby, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15620 Edgewood Dr, Suite 240, Brainerd, MN 56401 Phone: 218-454-7012 | |
Lepmiz Speech-language Pathology, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Nw 6th St, Brainerd, MN 56401 Phone: 218-824-7030 Fax: 218-824-7030 | |
Kristen Elliott, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 14890 Beaver Dam Rd, Brainerd, MN 56401 Phone: 218-297-1605 Fax: 320-245-1008 | |
Kari Johnson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2016 S 6th St, Brainerd, MN 56401 Phone: 218-828-7375 Fax: 218-825-7379 |